NATR Q1 2026 Earnings Strong EPS Surprise Amid Quiet Revenue Disclosures SOLV Q1 2026 Earnings EPS Beat by 73 Amid Operational Efficiency LIQT Q1 2026 Earnings WiderThanExpected Loss Stirs Caution GEL Q1 2026 Earnings Significant EPS Miss Amid Challenging Conditions Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending EHAB Q4 2025 Earnings EPS Misses Estimate by 31 Amid Operational Challenges